A detailed history of Grace & White Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Grace & White Inc holds 29,000 shares of NVO stock, worth $2.53 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
29,000
Previous 29,000 -0.0%
Holding current value
$2.53 Million
Previous $4.14 Million 16.57%
% of portfolio
0.78%
Previous 0.94%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$122.71 - $146.91 $490,840 - $587,640
-4,000 Reduced 12.12%
29,000 $4.14 Million
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $1.5 Million - $3.29 Million
16,500 Added 100.0%
33,000 $3 Million
Q2 2023

Jul 26, 2023

BUY
$155.98 - $172.65 $1.72 Million - $1.9 Million
11,000 Added 200.0%
16,500 $2.67 Million
Q1 2023

May 01, 2023

BUY
$132.34 - $159.14 $727,870 - $875,269
5,500 New
5,500 $875,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Grace & White Inc Portfolio

Follow Grace & White Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grace & White Inc , based on Form 13F filings with the SEC.

News

Stay updated on Grace & White Inc with notifications on news.